spirogermanium has been researched along with methotrexate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badger, AM; DiMartino, MJ; Mirabelli, CK; Swift, BA | 1 |
Harris, C; Salgo, MP; Tanowitz, HB; Wittner, M | 1 |
Bellamy, AS; Hepburn, PJ; Hill, BT; Masters, JR; Metcalfe, S; Whelan, RD | 1 |
3 other study(ies) available for spirogermanium and methotrexate
Article | Year |
---|---|
Inhibition of autoimmune disease and the generation of suppressor cells by spirogermanium: a biological profile similar to total lymphoid irradiation.
Topics: Animals; Antineoplastic Agents; Arthritis, Experimental; Autoimmune Diseases; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Lymphatic Irradiation; Methotrexate; Organometallic Compounds; Rats; Spiro Compounds; Spleen; T-Lymphocytes, Regulatory | 1989 |
In vitro assessment of antimicrobial agents against Toxoplasma gondii.
Topics: Animals; Anti-Infective Agents; Cell Line; Clindamycin; Drug Resistance; Eflornithine; Fluorouracil; Leucomycins; Methotrexate; Organometallic Compounds; Pyrimethamine; Rats; Spiro Compounds; Sulfadiazine; Toxoplasma | 1988 |
Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Survival; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Drug Synergism; Fluorouracil; Germanium; Humans; Methotrexate; Organometallic Compounds; Spiro Compounds; Tumor Stem Cell Assay | 1984 |